• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HO-1 的高表达预示着卵巢癌患者预后不良,并促进卵巢癌细胞的增殖和侵袭。

High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.

机构信息

Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong, People's Republic of China.

出版信息

Clin Transl Oncol. 2018 Apr;20(4):491-499. doi: 10.1007/s12094-017-1738-7. Epub 2017 Aug 14.

DOI:10.1007/s12094-017-1738-7
PMID:28808929
Abstract

PURPOSE

HO-1 has been proved to be associated with tumor aggressivity and poor prognosis in various cancers. Our study provides the first study to demonstrate the relationship of HO-1 expression and clinical characteristics in ovarian cancer patients.

METHODS

Immunohistochemistry and western blotting were used to examine the expression of HO-1 in tissue species and fresh tissues. CCK-8 was used to investigate cell viability. Transwell chamber was performed to estimate migration and invasion capacities in A2780 and Skov-3 cells.

RESULTS

Immunohistochemistry and western blotting showed that the expression of HO-1 was higher in ovarian cancer tissues than normal ovarian tissues. High expression of HO-1 was significantly associated with serous ovarian cancer, high FIGO stage, lymph node metastasis, and non-optimal debulking. Patients with high expression of HO-1 exhibited an unfavorable prognosis. In vitro inducing the expression of HO-1 promoted the proliferation and metastasis of A2780 and Skov-3 cells, with the increased expressions of mesenchymal marker (Vimentin), epithelial-mesenchymal transition-associated transcript factor (Zeb-1), anti-apoptotic protein (Bcl-2), and the decreased expressions of epithelial marker (Keratin) and pro-apoptotic protein (Bax). Meanwhile, after incubating A2780 and Skov-3 together with HO-1 inhibitor, above results could be reversed.

CONCLUSION

HO-1 might be a potential marker for prediction of ovarian cancer prognosis and a target for ovarian cancer treatment.

摘要

目的

HO-1 已被证明与多种癌症的肿瘤侵袭性和不良预后相关。本研究首次证明了 HO-1 表达与卵巢癌患者临床特征的关系。

方法

免疫组织化学和 Western blot 用于检测组织标本和新鲜组织中 HO-1 的表达。CCK-8 用于研究 A2780 和 Skov-3 细胞的活力。Transwell 室用于评估迁移和侵袭能力。

结果

免疫组织化学和 Western blot 显示,HO-1 在卵巢癌组织中的表达高于正常卵巢组织。HO-1 的高表达与浆液性卵巢癌、FIGO 高分期、淋巴结转移和非最佳减瘤术显著相关。HO-1 高表达的患者预后不良。体外诱导 HO-1 的表达促进了 A2780 和 Skov-3 细胞的增殖和转移,间充质标志物(波形蛋白)、上皮间质转化相关转录因子(Zeb-1)、抗凋亡蛋白(Bcl-2)的表达增加,而上皮标志物(角蛋白)和促凋亡蛋白(Bax)的表达减少。同时,在用 HO-1 抑制剂孵育 A2780 和 Skov-3 后,上述结果可以逆转。

结论

HO-1 可能是预测卵巢癌预后的潜在标志物,也是卵巢癌治疗的靶点。

相似文献

1
High expression of HO-1 predicts poor prognosis of ovarian cancer patients and promotes proliferation and aggressiveness of ovarian cancer cells.HO-1 的高表达预示着卵巢癌患者预后不良,并促进卵巢癌细胞的增殖和侵袭。
Clin Transl Oncol. 2018 Apr;20(4):491-499. doi: 10.1007/s12094-017-1738-7. Epub 2017 Aug 14.
2
CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.细胞周期蛋白依赖性激酶3(CDKN3)是一种独立的预后因素,可促进卵巢癌中卵巢癌细胞的增殖。
Oncol Rep. 2014 Apr;31(4):1825-31. doi: 10.3892/or.2014.3045. Epub 2014 Feb 20.
3
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.在非浆液性上皮性卵巢癌患者中,FOXM1表达与化疗耐药及不良预后显著相关。
J Exp Clin Cancer Res. 2017 May 8;36(1):63. doi: 10.1186/s13046-017-0536-y.
4
High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.细胞分裂周期蛋白6(CDC6)的高表达与上皮性卵巢癌的细胞增殖加速及预后不良相关。
Pathol Res Pract. 2016 Apr;212(4):239-46. doi: 10.1016/j.prp.2015.09.014. Epub 2015 Sep 18.
5
SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.SALL4是浆液性卵巢癌预后不良的一个标志物,可促进侵袭和转移。
Oncol Rep. 2016 Mar;35(3):1796-806. doi: 10.3892/or.2016.4545. Epub 2016 Jan 5.
6
Elevated Cathepsin K potentiates metastasis of epithelial ovarian cancer.组织蛋白酶 K 升高促进上皮性卵巢癌转移。
Histol Histopathol. 2018 Jul;33(7):673-680. doi: 10.14670/HH-11-960. Epub 2018 Jan 5.
7
Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.Basigin-2 是主要的 Basigin 异构体,可促进肿瘤细胞迁移和侵袭,并与上皮性卵巢癌的不良预后相关。
J Transl Med. 2013 Apr 8;11:92. doi: 10.1186/1479-5876-11-92.
8
Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer.MNK1 在卵巢上皮性癌预后预测及化疗开发中的意义。
Clin Transl Oncol. 2017 Sep;19(9):1107-1116. doi: 10.1007/s12094-017-1646-x. Epub 2017 Mar 22.
9
Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis.上皮性卵巢癌细胞中层粘连蛋白A而非层粘连蛋白C表达的缺失与转移及不良预后相关。
Pathol Res Pract. 2015 Feb;211(2):175-82. doi: 10.1016/j.prp.2014.11.008. Epub 2014 Nov 26.
10
Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.中心体蛋白55的上调与上皮性卵巢癌的不良预后和肿瘤侵袭相关。
Tumour Biol. 2016 May;37(5):6239-54. doi: 10.1007/s13277-015-4419-6. Epub 2015 Nov 28.

引用本文的文献

1
DLX4 regulates rheumatoid arthritis fibroblast-like synoviocytes invasiveness and a cancer transcriptomic signature.DLX4调节类风湿性关节炎成纤维细胞样滑膜细胞的侵袭性及一种癌症转录组特征。
Sci Rep. 2025 Jul 11;15(1):25164. doi: 10.1038/s41598-025-08960-w.
2
Synergistic effects of HO-1 inhibition and chemotherapy on tumor proliferation and immune infiltration: An in vitro and in vivo approach to enhancing prostate cancer treatment.血红素加氧酶-1抑制与化疗对肿瘤增殖和免疫浸润的协同作用:一种增强前列腺癌治疗效果的体内外研究方法
Transl Oncol. 2025 Apr;54:102339. doi: 10.1016/j.tranon.2025.102339. Epub 2025 Mar 3.
3
NADPH-Independent Fluorescent Probe for Live-Cell Imaging of Heme Oxygenase-1.

本文引用的文献

1
MicroRNA-1304 suppresses human non-small cell lung cancer cell growth in vitro by targeting heme oxygenase-1.微小RNA-1304通过靶向血红素加氧酶-1抑制人非小细胞肺癌细胞的体外生长。
Acta Pharmacol Sin. 2017 Jan;38(1):110-119. doi: 10.1038/aps.2016.92. Epub 2016 Sep 19.
2
Blocking heme oxygenase-1 by zinc protoporphyrin reduces tumor hypoxia-mediated VEGF release and inhibits tumor angiogenesis as a potential therapeutic agent against colorectal cancer.用锌原卟啉阻断血红素加氧酶-1可减少肿瘤缺氧介导的血管内皮生长因子释放,并抑制肿瘤血管生成,作为一种针对结直肠癌的潜在治疗药物。
J Biomed Sci. 2016 Jan 28;23:18. doi: 10.1186/s12929-016-0219-6.
3
用于血红素加氧酶-1活细胞成像的不依赖NADPH的荧光探针。
ACS Sens. 2025 Jan 24;10(1):499-506. doi: 10.1021/acssensors.4c02978. Epub 2025 Jan 2.
4
Dysregulation of Peripheral Blood Mononuclear Cells and Immune-Related Proteins during the Early Post-Operative Immune Response in Ovarian Cancer Patients.卵巢癌患者术后早期免疫反应期间外周血单个核细胞和免疫相关蛋白的失调
Cancers (Basel). 2023 Dec 30;16(1):190. doi: 10.3390/cancers16010190.
5
The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients.肿瘤相关巨噬细胞的免疫抑制途径受胶质母细胞瘤患者血红素加氧酶-1 的控制。
Int J Cancer. 2022 Dec 15;151(12):2265-2277. doi: 10.1002/ijc.34270. Epub 2022 Sep 15.
6
Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy.HO-1 表达对接受新辅助化疗的乳腺癌患者的预测和预后影响。
Breast Cancer Res Treat. 2022 Jun;193(2):393-403. doi: 10.1007/s10549-022-06565-9. Epub 2022 Mar 18.
7
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis.不同 BRD4 亚型的作用及其对高级别浆液性卵巢癌发病机制的贡献。
Mol Cancer. 2021 Nov 10;20(1):145. doi: 10.1186/s12943-021-01424-5.
8
Heme oxygenase 1: a novel oncogene in multiple gynecological cancers.血红素加氧酶 1:多种妇科癌症中的新型癌基因。
Int J Biol Sci. 2021 Jun 1;17(9):2252-2261. doi: 10.7150/ijbs.61073. eCollection 2021.
9
Clinical Significance of Heme Oxygenase 1 in Tumor Progression.血红素加氧酶1在肿瘤进展中的临床意义
Antioxidants (Basel). 2021 May 17;10(5):789. doi: 10.3390/antiox10050789.
10
Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation.姜黄素复合物对 MDA-MB-231 乳腺癌细胞增殖的影响。
Int J Oncol. 2020 Aug;57(2):445-455. doi: 10.3892/ijo.2020.5065. Epub 2020 May 14.
Heme oxygenase-1: emerging target of cancer therapy.
血红素加氧酶-1:癌症治疗的新兴靶点。
J Biomed Sci. 2015 Mar 21;22(1):22. doi: 10.1186/s12929-015-0128-0.
4
Cancer statistics, 2015.癌症统计数据,2015 年。
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29. doi: 10.3322/caac.21254. Epub 2015 Jan 5.
5
Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer.血红素加氧酶-1的表达与甲状腺癌的肿瘤侵袭性及BRAF V600E表达相关。
Histopathology. 2015 Feb;66(3):447-56. doi: 10.1111/his.12562. Epub 2014 Nov 25.
6
Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.锌原卟啉IX增强肝癌细胞对顺铂的化疗反应。
World J Gastroenterol. 2014 Jul 14;20(26):8572-82. doi: 10.3748/wjg.v20.i26.8572.
7
Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity.循环一氧化碳水平升高的结直肠癌患者中血红素加氧酶-1的上调可能影响化疗敏感性。
BMC Cancer. 2014 Jun 14;14:436. doi: 10.1186/1471-2407-14-436.
8
Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.血红素加氧酶-1在人脑胶质瘤中的表达及其与星形细胞瘤患者预后不良的相关性。
Tumour Biol. 2014 Mar;35(3):2803-15. doi: 10.1007/s13277-013-1373-z.
9
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth.一氧化碳加速代谢衰竭以抑制肿瘤生长。
Cancer Res. 2013 Dec 1;73(23):7009-21. doi: 10.1158/0008-5472.CAN-13-1075. Epub 2013 Oct 11.
10
High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients.血红素加氧酶-1 的高表达与非小细胞肺癌患者的肿瘤侵袭性和不良临床结局相关。
Cell Oncol (Dordr). 2012 Dec;35(6):461-71. doi: 10.1007/s13402-012-0105-5. Epub 2012 Oct 10.